A study looking at blood levels of chemotherapy drugs in people with Ewing's sarcoma (PK 2013 01)

Coronavirus (COVID-19)

We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.

Read about coronavirus and cancer

Cancer type:

Children's cancers
Ewing's sarcoma
Sarcoma

Status:

Open

Phase:

Pilot

This study is looking at what happens to chemotherapy drugs in the body during treatment for Ewing’s sarcoma. The study is supported by Cancer Research UK.

This study is for both adults and children. We use the term ‘you’ in this summary, but of course if you are a parent, we are referring to your child.

More about this trial

Treatment for Ewing’s sarcoma usually includes chemotherapy. You may have treatment that includes the drugs:

Doctors call this VDC/IE.

We know from research that there are variations in how people get rid of these drugs from their bodies. In this study, researchers are measuring levels of the drugs in the blood after treatment. It is called a pharmacokinetic study.

The main aims of the study are to see

  • If the blood levels influence the side effects people have and their response to the drugs
  • How the blood levels vary in people of different ages

Taking part in this study will not affect the treatment you have. The results may improve the way doctors use these chemotherapy drugs in the future.

Who can enter

You may be able to enter this study if you

  • Have Ewing’s sarcoma and are having VDC/IE chemotherapy as part of your treatment
  • Have had a tube put into your chest to give drugs directly into one of your major blood vessels (a central line)

You cannot enter the study if

  • You are having another type of chemotherapy that is not standard treatment
  • The doctors running the study don’t think it would be right for you to take part

Trial design

The study will recruit 140 people having chemotherapy for Ewing’s sarcoma.

You have chemotherapy in cycles of treatment. If you take part in this study, the study team will take a number of blood samples during 2 cycles of your chemotherapy treatment.

They will take the blood from your central line so you won’t need to have any extra needles.

The study team will also take extra samples to study certain genes that may control how fast the drugs are removed from your body and to see if they can predict which patients may be more likely to have side effects. They will take this sample before you start your 1st cycle of chemotherapy. The researchers want to see if they can work out at an early stage in treatment who is likely to get infections or a sore mouth because of the chemotherapy.

Hospital visits

Taking part in the study doesn’t involve any extra hospital visits.

Side effects

There are no side effects from taking part in this study.

Location

Aberdeen
Belfast
Birmingham
Bristol
Cambridge
Cardiff
Edinburgh
Glasgow
Leeds
Liverpool
London
Manchester
Newcastle upon Tyne
Nottingham
Oxford
Sheffield
Southampton

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Quentin Campbell Hewson

Supported by

Cancer Research UK
The Newcastle upon Tyne Hospitals NHS Foundation Trust
University of Newcastle

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

11910

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Around 1 in 5 people take part in clinical trials

3 phases of trials

Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think